SEC Filing Summary: GSK Plc (Form 6-K)
Business Context and Reporting Period
This Form 6-K filing by GSK Plc, a Foreign Private Issuer, reports a transaction in the company's own shares. The filing date is July 7, 2025, covering share repurchase activity that occurred on July 4, 2025. The transaction was executed through Merrill Lynch International under a non-discretionary agreement established on June 4, 2025.
Key Financial Metrics and Transaction Details
The filing details a specific block of share buybacks rather than full-period financial results (revenue, profit, or cash flow are not reported in this document).
- Shares Purchased: 484,578 ordinary shares of 31½ pence each.
- Price Range: Lowest price paid was 1,388.00 GBp; highest price paid was 1,415.00 GBp.
- Average Price: Volume-weighted average price paid was 1,400.75 GBp.
- Trading Venue: All purchases were executed on the London Stock Exchange (XLON).
- Treasury Holdings: Following this purchase, GSK holds 228,112,876 ordinary shares in treasury.
- Shares in Issue: 4,087,268,974 ordinary shares (excluding treasury shares).
- Voting Rights: Treasury shares represent 5.58% of total voting rights.
Material Changes and Program Progress
This transaction is part of an ongoing buyback program. Since the program's resumption or specific agreement date of June 4, 2025, the Company has purchased an aggregate of 9,978,493 ordinary shares. The filing confirms the increase in treasury stock and the corresponding reduction in shares available for public trading, though the total number of voting rights remains constant at 4,087,268,974 for shareholder notification calculations.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operational performance, or discussion of risks and contingencies. It is a statutory disclosure of a completed capital allocation event. The shares purchased are held as Treasury shares.
Investor Verification Checklist
- Verify the total cumulative buyback volume since June 4, 2025 (stated as 9,978,493 shares).
- Confirm the current percentage of voting rights held in treasury (5.58%) against regulatory thresholds.
- Review the remaining authorization under the existing buyback program to assess future capital return capacity.
- Check the impact of the increased treasury share count on earnings per share (EPS) calculations in upcoming financial reports.